RPA1 and colonic neoplasm: Altogether, these results indicate a potential oncogenic role of RPA1 in BRAFV600E-mutated colon cancer and suggest that upregulation of RPA1 expression is a molecular feature of BRAFV600E-mutated colon cancer that could be associated with the development of vemurafenib-resistant phenotype.